Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 8 | Starlite/ChEMBL | References |
Homo sapiens | mitogen-activated protein kinase 10 | Starlite/ChEMBL | References |
Homo sapiens | mitogen-activated protein kinase 14 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 14 | 360 aa | 336 aa | 33.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Leishmania major | developmentally regulated phosphoprotein-like protein | 0.035 | 0.5231 | 1 |
Trypanosoma cruzi | developmentally regulated phosphoprotein, putative | 0.035 | 0.5231 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0153 | 0.071 | 0.1358 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.035 | 0.5231 | 0.4867 |
Loa Loa (eye worm) | CMGC/MAPK/JNK protein kinase | 0.0557 | 1 | 1 |
Brugia malayi | kinase, mitochondrial precursor | 0.035 | 0.5231 | 0.4867 |
Trypanosoma brucei | developmentally regulated phosphoprotein | 0.035 | 0.5231 | 1 |
Echinococcus granulosus | Pyruvate dehydrogenase lipoamide kinase | 0.035 | 0.5231 | 0.4867 |
Schistosoma mansoni | pyruvate dehydrogenase | 0.035 | 0.5231 | 0.0858 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0153 | 0.071 | 0.1358 |
Loa Loa (eye worm) | hypothetical protein | 0.035 | 0.5231 | 0.4867 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0557 | 1 | 1 |
Echinococcus multilocularis | Pyruvate dehydrogenase (lipoamide) kinase | 0.035 | 0.5231 | 0.4867 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0153 | 0.071 | 0.1358 |
Echinococcus granulosus | c-Jun N-terminal kinases | 0.0557 | 1 | 1 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0153 | 0.071 | 0.1358 |
Echinococcus multilocularis | c Jun NH2 terminal kinase | 0.0557 | 1 | 1 |
Toxoplasma gondii | ATPase/histidine kinase/DNA gyrase B/HSP90 domain-containing protein | 0.0142 | 0.0447 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.007 uM | Inhibition of hexa-His-tagged JNK3 expressed in baculoviral system using GST-tagged cJun as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting | ChEMBL. | 22244937 |
IC50 (binding) | = 0.01 uM | Inhibition of hexa-His-tagged JNK2 expressed in baculoviral system using GST-tagged cJun as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting | ChEMBL. | 22244937 |
IC50 (binding) | = 0.051 uM | Inhibition of hexa-His-tagged JNK1 expressed in baculoviral system using GST-tagged c-Jun as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting | ChEMBL. | 22244937 |
IC50 (binding) | = 4.2 uM | Inhibition of p38alpha using myelin basic protein as substrate preincubated for 15 mins prior ATP addition measured after 60 mins by scintillation counting | ChEMBL. | 22244937 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.